Albumin and lipid enriched albumin for the critically ill

ISSN: 00045772
12Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

Abstract

Albumin, the principal transporter of plasma fatty acids, binds to majority of the drugs ingested, traps oxygen radicals and has potent anti-oxidant actions. Albumin binds to its specific binding sites on vascular endothelial cells and thus, prevents endothelial apoptosis. Albumin regulates the enzyme pyruvate dehydrogenase, the flux of glucose and lactate in astrocytes, and enhances the formation of anti-inflammatory lipoxins, resolvins and protectins from docosahexaenoic acid (DHA) and other polyunsaturated fatty acids that, in turn, could limit ischemia-induced neuronal damage. This may explain the beneficial action of DHA-enriched albumin in stroke and other critical diseases. © JAPI 2009.

Cite

CITATION STYLE

APA

Das, U. N. (2009, January). Albumin and lipid enriched albumin for the critically ill. Journal of Association of Physicians of India.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free